I Richard Steinhart
Affiliations
- Chief Financial Officer at Bioxcel Therapeutics Inc. (BTAI), 2024-10-04
- at Atossa Therapeutics Inc. (ATOS), 2024-07-01
- Director at Actinium Pharmaceuticals Inc. (ATNM), 2023-12-29
- Chief Financial Officer at Mela Sciences Inc. (MELA), 2013-08-08
- Director at Manhattan Pharmaceuticals Inc (MHAN), 2010-03-10
Insider Trading: Purchases See All
Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|---|
BTAI | $5.20 | 500 | Officer | 1,500 | 2018-12-03 | Filing | |
BTAI | $5.00 | 500 | Officer | 1,000 | 2018-11-30 | Filing | |
BTAI | $5.00 | 500 | Officer | 500 | 2018-11-29 | Filing | |
ATNM | $2.01 | 2,500 | Director | 2,500 | 2016-04-14 | Filing | |
MELA | $0.81 | 3,000 | Officer | 4,000 | 2013-06-25 | Filing |
Insider Trading: Sales See All
Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|---|
BTAI | $0.55 | 7,175 | Officer | 20,279 | 2024-10-03 | Filing | |
BTAI | $0.69 | 356 | Officer | 6,204 | 2024-09-16 | Filing | |
BTAI | $1.26 | 372 | Officer | 5,476 | 2024-06-17 | Filing | |
BTAI | $2.64 | 1,069 | Officer | 4,765 | 2024-04-04 | Filing | |
BTAI | $27.17 | 5,000 | Officer | 1,500 | 2023-05-15 | Filing |